Add Yahoo as a preferred source to see more of our stories on Google. “GLP-1 medications affect metabolism by altering how our brains balance fat burning and fat storage. They make it slightly easier ...

If you happen to sit next to Mima Mendoza on a train or stand behind her in a checkout line, you might get an earful about the benefits of lifting weights. “I’ve become like the person at the train ...

Clinical evidence has long suggested that the use of GLP-1 medications is linked to lower substance use. It’s also been speculated among patients taking the medications. Social drinkers, for example, ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Dieticians are warning that GLP-1 use can lead to extreme malnutrition, manifesting in diseases like scurvy, amid findings that the vast majority of studies fail to consider patients’ eating habits.

Americans are driving less, skipping meals and putting off big life moves, like buying homes or having children, to keep up with health care costs, according to two Gallup polls released Thursday.

In case you've faced some hurdles solving the clue, Skip over, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

Share on Pinterest GLP-1s linked to higher osteoporosis risk but they may bring some benefits, too, new studies find. Image credit: SweetBunFactory/Getty Images A large percentage of Americans are ...

Evidence continues to mount suggesting that GLP-1 drugs may help people cut back on cigarettes, drinking and opioid use. Subscribe to read this story ad-free Get unlimited access to ad-free articles ...

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...

As GLP-1 use has expanded well beyond obesity and diabetes, clinicians are encountering a broader range of real-world symptoms — some anticipated, others less clearly defined. For primary care ...